We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
In 2006, BIS undertook a stock-take of regenerative medicine in the UK. This report provides an updated overview of the UK patent landscape.
This report sets out a summary of DECC’s work to date assessing the Energy Delivery Landscape.
First published during the 2015 to 2016 Cameron Conservative government
Recordati Rare Diseases T/A Recordati Rare Diseases UK Ltd has made the MHRA aware that specific batches of Pedea 5 mg/ml solution for injection have been packaged with the incorrect Product Information Leaflet (PIL).
Cases of severe cutaneous adverse reactions, including Stevens-Johnsons syndrome (SJS) and toxic epidermal necrolysis (TEN), have been reported in patients treated with immune-stimulatory anti-cancer drugs, including atezolizumab. Advise patients to be vigilant for the signs of severe skin reactions and...
Patients who present with acute or worsening signs and symptoms of keratitis should be referred promptly to an ophthalmology specialist.
Recombinant human erythropoietin (r-HuEPO) treatment has been associated with very rare cases of life-threatening severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Withdraw r-HuEPOs permanently in patients who develop severe skin reactions such as...
The UK and US are working on technology that could be used to provide early warning protection for cities and major events.
First published during the 2022 to 2024 Sunak Conservative government
Severe skin reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported during treatment with capecitabine.
Erythema multiforme, Stevens Johnson syndrome and toxic epidermal necrolysis reported in association with isotretinoin - may result in hospitalisation, disability, life-threatening events, or death.
Risk of serious skin-related adverse drug reactions, including Stevens-Johnson syndrome, occurring with carbamazepine may be increased in the presence of the HLA-A*3101 allele in patients of European descent or Japanese origin.
Systemic piroxicam should be initiated only by specialists as a second-line treatment for arthritis, with patients who currently take piroxicam reassessed at a routine appointment.
Employment Appeal Tribunal judgment of Judge Eady on 18 January 2018.
Employment Tribunal decision.
Multi-million pound contract for assessment of active protection systems.
Department of Health ministers agreed to refer the following topics to the National Institute for Health and Clinical Excellence (NICE).
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
An innovative project to mimic the dynamic colours of nature and create a new range of paints is being promoted at Chelsea Flower Show.
Research into using microbicides to help women protect themselves from HIV is being funded by the Department for International Development (DFID).
Upper Tribunal Administrative Appeals Chamber decision by Judge Jacobs on 13 October 2017.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).